Innovation in Vascular Health: Femtosecond Laser Atherectomy for Safe and Effective Treatment

As individuals age, the prevalence of blood vessel blockages increases, posing a threat to their health span. Existing market treatments prove inadequate in preventing recurring blockages. Atherectomy, crucial for clearing blocked vessels, encounters inherent risks in current methods, demanding a safer and more efficient solution. The challenge lies in potential harm from abrasive tools and risks associated with nanosecond lasers, especially in treating highly calcified plaque.

Dr. Viktoras Lisicovas, a former Technology Pioneer Fellow under the OIST Innovation Proof of Concept Program, is leading this exciting project. He and his team not only acknowledge this challenge but also actively strive to introduce an innovative femtosecond laser-based atherectomy system to the market. Unlike traditional methods, this solution eradicates the need for abrasive tools or heat-generating nanosecond lasers, significantly reducing associated risks in the procedure

This groundbreaking technology not only enhances removal performance but also minimizes thermal damage to surrounding tissues. By utilizing near-infrared light instead of potentially harmful ultraviolet radiation, this system ensures greater biocompatibility and reduces potential complications. This results in mitigated inflammation, accelerated patient recovery, and a lower risk of plaque recurrence.

The team is currently finalizing the first prototype of this innovative medical device. Looking forward, they aspire to attract venture capital interest or secure a technology licensing partner to facilitate further development and refinement, ensuring successful progression toward market readiness. The team's optimism about the potential impact of their work is driving active exploration of collaboration and support avenues to advance this groundbreaking medical technology.

The femtosecond laser-based atherectomy system signifies a paradigm shift in minimally invasive endovascular therapy. With a firm focus on safety and efficiency, the team actively explores avenues to bring this groundbreaking solution to the market, promising to transform the landscape of vascular care.